214
Participants
Start Date
May 3, 2023
Primary Completion Date
June 30, 2027
Study Completion Date
December 31, 2027
Nicotinamide riboside
Oral NR, 1g/day per os for 8 weeks
Placebo
Visually identical pill to NR, daily per os for 8 weeks
RECRUITING
University of Oklahoma Health Sciences Center, Oklahoma City
Collaborators (1)
University of Pennsylvania
OTHER
Oklahoma Medical Research Foundation
OTHER
Elysium Health
INDUSTRY
University of Oklahoma
OTHER